Neptune Medical Appoints Dr. Fred Moll as Chairman of the Board

Rhea-AI Summary

Neptune Medical (Ticker: NPTM) appoints Dr. Fred Moll, a renowned figure in the medical technology industry, as Chairman of the Board. Dr. Moll, known as the father of medical robotics, brings extensive experience from his roles at Sonder Capital, Intuitive Surgical, and Auris Health. His appointment signifies Neptune Medical's commitment to advancing healthcare technology.

Positive

• Dr. Fred Moll's appointment brings a wealth of experience and expertise to Neptune Medical, signaling the company's dedication to advancing healthcare technology.

Negative

• None.

BURLINGAME, Calif.--(BUSINESS WIRE)-- Neptune Medical, a leading innovator in medical technology, is pleased to announce the appointment of Dr. Fred Moll as Chairman of the Board. Dr. Moll, a seasoned entrepreneur and influential figure in the medical technology industry considered to be the father of medical robotics, brings a wealth of experience and expertise to Neptune Medical.

Dr. Fred Moll is currently a Managing Partner at Sonder Capital, a venture capital firm focused on investing in breakthrough healthcare technologies. His illustrious career includes founding Intuitive Surgical, a pioneer in robotic-assisted minimally invasive surgery, and Auris Health, which was acquired by Johnson & Johnson.

In addition to his role at Sonder Capital, Dr. Moll currently serves on the boards of several healthcare companies, including Procept BioRobotics, Inc. (NASDAQ: PRCT) as Chairman, and ShockWave Medical (NASDAQ: SWAV), contributing his strategic vision and leadership to guide these companies in their respective fields.

"We are thrilled to welcome Dr. Fred Moll as the Chairman of the Board at Neptune Medical," said Alex Tilson, Founder and CEO of Neptune Medical. "His unparalleled experience in the medical technology sector will be invaluable as we continue to grow and advance our mission of transforming healthcare with innovative products."

As Chairman of the Board, Dr. Moll will provide strategic guidance and leadership to Neptune Medical, supporting the company in its mission to develop cutting-edge medical technologies that improve patient outcomes and enhance the efficiency of healthcare delivery across multiple clinical areas.

"I am honored to join Neptune Medical as Chairman of the Board," said Dr. Fred Moll. "I am excited about the opportunity to work with the talented team at Neptune Medical and contribute to the development of groundbreaking medical technologies that have the potential to make a significant impact on patient care."

About Neptune Medical

Neptune Medical is a Burlingame, Calif.-based medical technology company dedicated to developing innovative solutions that address the challenges faced by healthcare professionals and improve patient outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231120048805/en/

Michelle McAdam, Chronic Communications Inc.

michelle@chronic-comm.com, (310) 902-1274

Source: Neptune Medical

FAQ

Who is the new Chairman of the Board at Neptune Medical?

Neptune Medical has appointed Dr. Fred Moll, a seasoned entrepreneur and influential figure in the medical technology industry, as the new Chairman of the Board.

What is Dr. Fred Moll's background in the medical technology industry?

Dr. Fred Moll is known as the father of medical robotics and has extensive experience from his roles at Sonder Capital, Intuitive Surgical, and Auris Health.

What is the significance of Dr. Fred Moll's appointment for Neptune Medical?

Dr. Fred Moll's appointment signifies Neptune Medical's commitment to advancing healthcare technology and developing cutting-edge medical technologies.

What is the mission of Neptune Medical?

Neptune Medical aims to develop cutting-edge medical technologies that improve patient outcomes and enhance the efficiency of healthcare delivery across multiple clinical areas.